Systematic review and meta-analysis of performance of second-trimester nasal bone assessment in detection of fetuses with Down syndrome

Ultrasound in Obstetrics and Gynecology

Volumn 43, Issue 3, 2014, Pages 247-253

  Moreno Cid, M ^a   Rubio Lorente, A ^a   Rodriguez M J ^a   Bueno Pacheco, G ^a   Tenias J M ^a   Roman Ortiz C ^a   Arias, A ^a  

^a HOSPITAL GENERAL LA MANCHA CENTRO   (Spain)

Author keywords

absent nasal bone; hypoplasia; pregnancy; sensitivity; specificity; trisomy 21; ultrasonography

Indexed keywords

BIOMETRY; DOWN SYNDROME; ECHOGRAPHY; EMBRYOLOGY; FEMALE; FETUS ECHOGRAPHY; HUMAN; META ANALYSIS; NASAL BONE; NEWBORN; PREGNANCY; RECEIVER OPERATING CHARACTERISTIC; SECOND TRIMESTER PREGNANCY; SENSITIVITY AND SPECIFICITY;

BIOMETRY; DOWN SYNDROME; FEMALE; HUMANS; INFANT, NEWBORN; NASAL BONE; PREGNANCY; PREGNANCY TRIMESTER, SECOND; ROC CURVE; SENSITIVITY AND SPECIFICITY; ULTRASONOGRAPHY, PRENATAL;

EID: 84897742099     PISSN: 09607692     EISSN: 14690705     Source Type: Journal    
DOI: 10.1002/uog.13228     Document Type: Review

References (46)

1. Hook EB, Cross PK, Schereinemachers DM,. Chromosomal abnormality rates at amniocentesis and in live-born infants. JAMA 1983; 249: 2034-2038.
2. Penrose LS, Smith GF,. Down's Anomaly. Little Brown: Boston, MA, 1966.
3. Waitzman NJ, Romano PS, Scheffler RM,. Estimates of the economic costs of birth defects. Inquiry 1994; 31: 188-205.
4. Oberfield RG, Paul H,. Prematurity, birth defects, and early death: impact on the family. In: Child and Adolescent Psychiatry: A Comprehensive Textbook, Lewis M, (ed.). Williams & Wilkins Co.: Baltimore, MD, 1991.
5. Spencer K, Souter V, Tul N, Snijers R, Nicolaides KH,. A screening program for trisomy 21 at 10-14 weeks using fetal nuchal translucency, maternal serum free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A. Ultrasound Obstet Gynecol 1999; 13: 231-237.
6. Wald NJ, Rudnicka AR, Bestwick JP,. Sequential and contingent prenatal screening for Down syndrome. Prenat Diagn 2006; 26: 769-777.
7. Malone FD, Wald NJ, Canick JA, Ball RH, Nyberg DA, Comstock CH, D'Alton ME,. First and second trimester evaluation of risk (FASTER) Trial: principal results of the NICHD multicenter Down syndrome screening study. Am J Obstet Gynecol 2003; 189 (6 Suppl): S56.
8. Wald NJ, Rodeck C, Hackshaw AK, Walters J, Chitty L, Mackinson AM,. First and second trimester antenatal screening for Down's syndrome: the results of the serum, urine and ultrasound screening study (SURUSS). Health Tech Assess 2003; 7: 1-77.
9. Keeling JW, Hansen BF, Kjaer I,. Pattern of malformations in the axial skeleton in human trisomy 21 fetuses. Am J Med Genet 1997; 68: 466-471.
10. Cicero S, Curcio P, Papageorghiou A, Sonek J, Nicolaides K,. Absence of nasal bone in fetuses with trisomy 21 at 11-14 weeks gestation: an observational study. Lancet 2001; 358: 1665-1667.
11. Zoppi MA, Ibba RM, Axiana C, Floris M, Manca F, Monni G,. Absence of fetal nasal bone and aneuploidies at first-trimester nuchal translucency in unselected pregnancies. Prenat Diagn 2003; 23: 496-500.
12. Viora E, Masturzo B, Errante G, Sciarrone A, Bastonero S, Campogrande M,. Ultrasound evaluation of fetal nasal bone at 11-14 weeks of pregnancy and its potential role in Down syndrome risk assessment. Ultrasound Obstet Gynecol 2003; 22: 36-39.
13. Vintzileos A, Walters C, Yeo L,. Absent nasal bone in the prenatal detection of trisomy 21 in a high-risk population. Obstet Gynecol 2003; 101 (5 Pt 1): 905-908.
14. Bromley B, Lieberman E, Shipp TD, Benacerraf BR,. Fetal nasal bone length: a marker for Down syndrome in the second trimester. J Ultrasound Med 2002; 21: 1387-1394.
15. Cicero S, Sonek JD, Mckenna DS, Croom CS, Johnson L, Nicolaides KH,. Nasal bone hypoplasia in trisomy 21 at 15-22 weeks' gestation. Ultrasound Obstet Gynecol 2003; 21: 15-18.
16. Gianferrari EA, Benn PA, Dries L, Brault K, Egan J, Zelop CM,. Absent or shortened nasal bone length and the detection of Down syndrome in second-trimester fetuses. Obstet Gynecol 2007; 109: 371-375.
17. Cusick W, Shevell T, Duchan LS, Lupinacci CA, Terranova J, Crombleholme WR,. Likelihood ratios for fetal trisomy 21 based on nasal bone length in the second trimester: how best to define hypoplasia? Ultrasound Obstet Gynecol 2007; 30: 271-274.
18. Cusik W, Provenzano J, Sullivan CA, Gallousis FM, Rodis JF,. Fetal nasal bone length in euploid and aneuploid fetuses between 11 and 20 weeks' gestation: a prospective study. J Ultrasound Med 2004; 23: 1327-1333.
19. Odibo AO, Sehdev HM, Dunn L, McDonal R, Macones GA,. The association between fetal nasal bone hypoplasia and aneuploidy. Obstet Gynecol 2004; 104: 1229-1233.
20. Haynes RB, Wilczynski NL, for the Hedges Team. Optimal search strategies for retrieving scientifically strong studies of diagnosis from MEDLINE: analytical survey. BMJ 2004; 328: 1040.
21. Wilczynski NL, Haynes RB; Hedges Team. EMBASE search strategies for identifying methodologically sound diagnostic studies for use by clinicians and researchers. BMC Med 2005; 3: 7.
22. Checklist for diagnostic studies. Critical Appraisal Skills Programme. Making sense of evidence. http://www.casp-uk.net/ [Accessed 3 June 2013].
23. Zamora J, Abraira V, Muriel A, Khan K, Coomarasamy A,. Meta-DiSc: a software for meta-analysis of test accuracy data. BMC Medical Research Methodology 2006; 6: 31.
24. Sooklim R, Manotaya S,. Fetal facial sonographic markers for second trimester Down syndrome screening in a Thai population. Int J Gynaecol Obstet 2010; 111: 144-147.
25. Geipel A, Willruth A, Vieten J, Gembruch U, Berg C,. Nuchal fold thickness, nasal bone absence or hypoplasia, ductus venosus reversed flow and tricuspid valve regurgitation in screening for trisomies 21, 18 and 13 in the early second trimester. Ultrasound Obstet Gynecol 2010; 35: 535-539.
26. Odibo AO, Schoenborn JA, Haas K, Macones GA,. Does the combination of fronto-maxillary facial angle and nasal bone evaluation improve the detection of Down syndrome in the second trimester? Prenat Diagn 2009; 29: 947-951.
27. Hung JH, Fu CY, Chen CY, Chao KC, Hung J,. Fetal nasal bone length and Down syndrome during the second trimester in a Chinese population. J Obstet Gynaecol Res 2008; 34: 518-523.
28. Odibo AO, Sehdev HM, Gerkowicz S, Stamilio DM, Macones GA,. Comparison of the efficiency of second-trimester nasal bone hypoplasia and increased nuchal fold in Down syndrome screening. Am J Obstet Gynecol 2008; 199: 281-285.
29. Odibo AO, Sehdev HM, Stamilio DM, Cahill A, Dunn L, Macones GA,. Defining nasal bone hypoplasia in second-trimester Down syndrome screening: does the use of multiples of the median improve screening efficacy? Am J Obstet Gynecol 2007; 197: 361-364.
30. Naraphut B, Uerpairojkit B, Chaithongwatthana S, Tannirandorn Y, Tanawattanacharoen S, Manotaya S, Charoenvidhya D,. Nasal bone hypoplasia in trisomy 21 at 15 to 24 weeks' gestation in A high risk Thai population. J Med Assoc Thai 2006; 89: 911-917.
31. Odibo AO, Sehdev HM, Sproat L, Parra C, Odibo L, Dunn L, Macones GA,. Evaluating the efficiency of using second-trimester nasal bone hypoplasia as a single or a combined marker for fetal aneuploidy. J Ultrasound Med 2006; 25: 437-441.
32. Tran LT, Carr DB, Mitsumori LM, Uhrich SB, Shields LE,. Second-trimester biparietal diameter/nasal bone length ratio is an independent predictor of trisomy 21. J Ultrasound Med 2005; 24: 805-810.
33. Gamez F, Ferreiro P, Salmean JM,. Ultrasonographic measurement of fetal nasal bone in a low-risk population at 19-22 gestational weeks. Ultrasound Obstet Gynecol 2004; 23: 152-153.
34. Lee W, DeVore GR, Comstock CH, Kalache KD, McNie B, Chaiworapongsa T, Conoscenti G, Treadwell MC, Johnson A, Huang R, Romero R,. Nasal bone evaluation in fetuses with Down syndrome during the second and third trimesters of pregnancy. J Ultrasound Med 2003; 22: 55-60.
35. Lefebvre G, Vauthier-Brouzes D, Choukroun JB, Sebagh E, Bernard M, Brochet C, Lesourd S, Darbois Y,. [ Evaluation of the association of a serum marker and second trimester ultrasonography for the screening of trisomy 21 in women of less than 38 years. Prospective study of 5,163 patients ]. J Gynecol Obstet Biol Reprod (Paris) 1998; 27: 599-604.
36. Bunduki V, Ruano R, Miguelez J, Yoshizaki CT, Kahhale S, Zugaib M,. Fetal nasal bone length: reference range and clinical application in ultrasound screening for trisomy 21. Ultrasound Obstet Gynecol 2003; 21: 156-160.
37. Cusick W, Provenzano J, Sullivan CA, Gallousis FM, Rodis JF,. Fetal nasal bone length in euploid and aneuploid fetuses between 11 and 20 weeks' gestation. A prospective study. J Ultrasound Med 2004; 23: 1327-1333.
38. Viora E, Errante G, Sciarrone A, Bastonero S, Masturzo B, Martiny G, Campogrande M,. Fetal nasal bone and trisomy 21 in the second trimester. Prenat Diagn 2005; 25: 511-515.
39. Fichas de lectura crítica. Osteba. Servicio de Evaluaciõn de Tecnologías Sanitarias. Departamento de Sanidad y Conusmo del Gobierno vasco. http://www.lecturacritica.com/es/ [Accessed 3 June 2013].
40. Agathokleous M, Chaveeva P, Poon LCY, Kosinski P, Nicolaides KH,. Meta-analysis of second-trimester markers for trisomy 21. Ultrasound Obstet Gynecol 2013; 41: 247-261.
41. Guis F, Ville Y, Vincent Y, Doumerc S, Pons JC, Frydman R,. Ultrasound evaluation of the length of the nasal bones throughout gestation. Ultrasound Obstet Gynecol 1995; 5: 304-307.
42. Sonek J, McKenna D, Webb D, Croom C, Nicolaides K,. Nasal bone lengths throughout gestation: normal ranges based on 3537 fetal ultrasound measurements. Ultrasound Obstet Gynecol 2003; 21: 152-155.
43. Maymon R, Levinsohn-Tavor O, Cuckle H, Tovbin Y, Dreazen E, Wiener Y, Herman A,. Second trimester ultrasound prenasal thickness combined with nasal bone length: a new method of Down syndrome screening. Prenat Diagn 2005; 25: 906-911.
44. Maymon R, Ushakov F, Waisman D, Cuckle H, Tovbin Y, Herman A,. A model for second-trimester Down syndrome sonographic screening based on facial landmarks and digit length measurement. Ultrasound Obstet Gynecol 2006; 27: 290-295.
45. De Jong-Pleij E, Vos F, Ribbert L, Pistorius L, Tromp E, Bilardo C,. Prenasal thickness-to-nasal bone length ratio: a strong and simple second-and third-trimester marker for trisomy 21. Ultrasound Obstet Gynecol 2012; 39: 185-190.
46. Gonzalez R, Aedo S, Dezerega V, Sepúlveda W,. Frontonasal fold thickness-to-nasal bone length ratio as a prenatal sonographic marker for trisomy 21 in a low-risk population. J Ultrasound Med 2013; 32: 795-800.